MW-150
CAS: 1628502-91-9
Ref. 3D-DQC50291
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
MW-150 is a monoclonal antibody that binds to the heavy chains of myasthenia gravis autoantibodies. It prevents the binding of these autoantibodies with muscle cells, which inhibits their effect on neuromuscular transmission. MW-150 has also been shown to have an inhibitory effect on intracellular signalling pathways in nerve cells, inhibiting neurotransmitter release and blocking calcium influx into the cell. The drug is injected intramuscularly or intravenously and can be used for long periods of time without any significant side effects. MW-150 has been tested in humans and found to be safe and well tolerated.
Chemical properties
Technical inquiry about: 3D-DQC50291 MW-150
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
